Related Experiment Video
Updated: Dec 17, 2025

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring
Published on: April 4, 2025
Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
Lisette Pregelj1, Damian C Hine2, Maria G Oyola-Lozada3
1School of Chemistry and Molecular Biosciences and Australian Institute for Business and Economics, The University of Queensland, St Lucia, Queensland 4072, Australia.
Abstract:
Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the global effort for pandemic vaccines.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Biopharmaceutical Factors Influencing Drug Product Design: Overview

